U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...

In the final days of 2024, three pharmaceutical giants sued the federal government. In their joint lawsuit, Amgen, Eli Lilly ...

Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

US-based biopharma giant on Monday opened its new technology and innovation centre in Hyderabad with its CEO Robert Bradway ...

Gemini Bioproducts, LLC ("GeminiBio"), a biopharma and advanced therapy raw materials supplier, and a portfolio company of ...

The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...

Global biotech leader Amgen opened its $200 million technology and innovation centre in Hyderabad, a facility that will help ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

Amgen invests $200M in India's tech center to leverage AI for drug development. The U.S. FDA seeks to rehire 300 staff ...